Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial (Q41169564)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2009
edit
Language Label Description Also known as
English
Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial
scientific article published on September 2009

    Statements

    Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial (English)
    1 reference
    Nitin Jain
    1 reference
    James M Reuben
    1 reference
    Changping Li
    1 reference
    Hui Gao
    1 reference
    Evan N Cohen
    1 reference
    David A Scheinberg
    1 reference
    1 September 2009
    1 reference
    115
    1 reference
    3924-3934
    1 reference
    17
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit